Goodrich Petroleum Announces Positive Well Data; Micron Technology gets BUY rating from The Street


Follow this company

Companies Mentioned

NYSE:GDP / NASDAQ:MU / NASDAQ:LXRX / NASDAQ:WBMD
04/15/2014 [ACCESSWIRE]

Goodrich Petroleum Corp. (NYSE: GDP) – For an in-depth report on Goodrich Petroleum Corp. follow: www.BullTrends.com/stockquote/GDP

Shares of Goodrich Petroleum Corp. closed up 30.22% on nearly 12.5 million shares traded on Monday. The stock was one of the biggest gainers on the NYSE. The company reported positive well results in its newly acquired acreage that's prospective for the Tuscaloosa Marine Shale. Its Blades 33H-1 well achieved a peak 24-hour average production rate of 1,270 barrels of oil equivalent per day, or BOE/d. Oil production was 1,250 barrels per day.

Micron Technology Inc. (NASDAQ: MU) - For an in-depth report on Micron Technology Inc. follow: www.BullTrends.com/stockquote/MU

Shares of Micron Technology closed up 3.64% on about 31 million shares traded on Monday. The stock was one of the most active stocks on the NASDAQ. The stock has been reiterated as a "buy" with a ratings score of B. "We rate MICRON TECHNOLOGY INC (MU) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook."

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) - For an in-depth report on Lexicon Pharmaceuticals, Inc. follow: www.BullTrends.com/stockquote/LXRX

Shares of LXRX closed down 2.52% on Monday with about 6.5 million shares traded. The company reported positive results in a clinical trial of type 1 diabetes drug LX4211. The trial found that the drug successfully reduced insulin use and improved glycemic control in patients with poorly controlled diabetes.

WebMD Health Corp. (NASDAQ: WBMD) – For an in-depth report on WebMD Health Corp. follow: www.BullTrends.com/stockquote/WBMD

WebMD Health Corp. closed up 16.46% on nearly 3.7 million shares traded. The stock was one of the biggest gainers on the NASDAQ after the company’s first-quarter update topped Wall Street expectations. The company also said that monthly traffic to its health network spiked 32% to 174 million unique users, while page views surged 26% to 3.5 billion.

 

Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.

COMMENTS

Leave a comment...
 * 

Your Name
 *